Vimarsana
Biggest News Aggregation in the World

Osian Evans News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Osian Evans. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Osian Evans Today - Breaking & Trending Today

Anger as Outlander fans flock to iconic ancient stones older than the Pyramids - forcing bosses to announce visitor charge - Vimarsana News

Anger as Outlander fans flock to iconic ancient stones older than the Pyramids - forcing bosses to announce visitor charge

Tourists could soon be forced to pay to visit the ancient Calanais Standing Stones which inspired Outlander.

Huge UK train station set to open new £2.5million Wetherspoons this year - Vimarsana News

Huge UK train station set to open new £2.5million Wetherspoons this year

A BRAND new Wetherspoons is set to open in London this summer - and it's going to be at one of the city's biggest train stations.Plans have been submi

JD Wetherspoon to open pub at Waterloo station - Vimarsana News

JD Wetherspoon to open pub at Waterloo station

Managed pubs operator JD Wetherspoon (JDW) is to open a new pub near BrewDog’s huge London site at The Sidings, Waterloo station.

JD Wetherspoon: Tim Martin to open pub at London Waterloo station investing millions and creating 120 jobs - Vimarsana News

JD Wetherspoon: Tim Martin to open pub at London Waterloo station investing millions and creating 120 jobs

The chain said it will pump £2.5m into development of the pub, and 120 full and part time jobs will be created as a result.

Source: cityam.com
STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024 - Vimarsana News

STORM Therapeutics to Present Data on its First-in-Class METTL1 tRNA Methyltransferase Inhibitors at AACR Annual Meeting 2024

Late breaking presentation on STORM’s METTL1 inhibitors, for the treatment of cancer, on 8 April 2024 26 March 2024, Cambridge, UK: STORM Therapeutics Ltd. (STORM), the clinical stage biotechnology company discovering and developing novel small molecule therapies targeting RNA modifying enzymes (RMEs) for...